Positive Rate and Quantification of Amyloid Pathology with [18f]florbetapir in the Urban Chinese Population.

Kun He,Binyin Li,Lin Huang,Jun Zhao,Fengchun Hua,Tao Wang,Junpeng Li,Jie Wang,Qi Huang,Keliang Chen,Shasha Xu,Shuhua Ren,Huawei Cai,Donglang Jiang,Jingchao Hu,Xingmin Han,Yihui Guan,Kewei Chen,Qihao Guo,Fang Xie
DOI: https://doi.org/10.1007/s00330-023-10366-z
IF: 7.034
2024-01-01
European Radiology
Abstract:Amyloid deposition is considered the initial pathology in Alzheimer’s disease (AD). Personalized management requires investigation of amyloid pathology and the risk factors for both amyloid pathology and cognitive decline in the Chinese population. We aimed to investigate amyloid positivity and deposition in AD patients, as well as factors related to amyloid pathology in Chinese cities. This cross-sectional multicenter study was conducted in Shanghai and Zhengzhou, China. All participants were recruited from urban communities and memory clinics. Amyloid positivity and deposition were analyzed based on amyloid positron emission tomography (PET). We used partial least squares (PLS) models to investigate how related factors contributed to amyloid deposition and cognitive decline. In total, 1026 participants were included: 768 participants from the community-based cohort (COMC) and 258 participants from the clinic-based cohort (CLIC). The overall amyloid-positive rates in individuals with clinically diagnosed AD, mild cognitive impairment (MCI), and normal cognition (NC) were 85.8 • We studied amyloid pathology and related risk factors in the Chinese population. •·The overall amyloid-positive rates in individuals with clinically diagnosed AD, MCI, and NC were 85.8 • These overall amyloid-positive rates were in close agreement with the corresponding prevalence for other populations.
What problem does this paper attempt to address?